Results 21 to 30 of about 2,158,008 (249)

Alpha-1 Antitrypsin Deficiency: Home Therapy

Frontiers in Pharmacology, 2021
While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation ...
Anna Annunziata, Maurizia Lanza, Antonietta Coppola, Paolo Andreozzi, Sara Spinelli, Giuseppe Fiorentino   +5 more
doaj   +1 more source

Alveolar ridge preservation reduces the need for ancillary bone augmentation in the context of implant therapy [PDF]

, 2022
BACKGROUND: There is limited information on the need for bone augmentation in the context of delayed implant placement whether alveolar ridge preservation (ARP) is previously performed or not.
Emilio Couso‐Queiruga, Mansouri, Cyrus J, Galindo-Moreno, Pablo, Gustavo Avila‐Ortiz, Alade, Azeez A., Allareddy, Trishul V., Trishul V. Allareddy, Azeez A. Alade, Couso‐Queiruga, Emilio, Allareddy, Trishul V, Galindo‐Moreno, Pablo, Avila‐Ortiz, Gustavo, Alade, Azeez A, Cyrus J. Mansouri, Couso-Queiruga, Emilio, Pablo Galindo‐Moreno, Avila-Ortiz, Gustavo, Mansouri, Cyrus J.   +17 more
core   +2 more sources

Alpha-1 Antitrypsin Deficiency-Associated Clinical Manifestations and Healthcare Resource Use in the United States

COPD, 2021
Pulmonary events (PEs) associated with alpha-1 antitrypsin deficiency (AATD) can have a severe clinical course and increase healthcare resource use (HRU). However, AATD-associated HRU and healthcare costs have not been extensively described.
Ernesto Mayen Herrera, Corey Joseph, Emily S. Brouwer, Vivek Gandhi, Michael Czorniak   +4 more
doaj   +1 more source

Augmenting Exposure Therapy: Mobile Augmented Reality for Specific Phobia [PDF]

Frontiers in Virtual Reality, 2020
New technologies, such as virtual reality (VR) and augmented reality (AR), can be used as an add-on to exposure therapy for common anxiety disorders. While the benefits of VR for exposure therapy have already been demonstrated extensively in research, AR applications are only just becoming widely available.
De Witte, Nele, Scheveneels, Sara, Sels, Romy, Debard, Glen, Hermans, Dirk, Van Daele, Tom   +5 more
openaire   +1 more source

“Metacognitive Reflection and Insight Therapy” (MERIT) for the Occupational Therapy Practitioner [PDF]

, 2022
Background: Metacognitive Reflection and Insight Therapy (MERIT) is a manualized, evidence-based approach that supports occupational participation through its focus on the inter-related constructs of meaning making, positionality, and self-definition ...
Lysaker, Paul H., Mahaffey, Lisa, Horsford, Caitlin, Wasmuth, Sally   +3 more
core   +1 more source

Gene augmentation therapy attenuates retinal degeneration in a knockout mouse model of Fam161a retinitis pigmentosa

, 2023
Photoreceptor cell degeneration and death is the major hallmark of a wide group of human blinding diseases including age-related macular degeneration and inherited retinal diseases such as retinitis pigmentosa. In recent years, inherited retinal diseases
Prakadeeswari Gopalakrishnan, Kostic, C., Dror Sharon, Sharon, D., Banin, E., Manar Salameh, Matsevich, C., Gopalakrishnan, P., Alexey Obolensky, Beryozkin, A., Arsenijevic, Y., Eyal Banin, Chen Matsevich, Ning Chang, Avigail Beryozkin, Corinne Kostic, Salameh, M., Chang, N., Obolensky, A., Yvan Arsenijevic   +19 more
core   +1 more source

Applying the Ecological Model of Human Performance and the SlutWalk Movement to Support those Affected by Rape Culture in the Context of Occupational Therapy [PDF]

, 2023
Improving the occupational lives of others is at the heart of occupational therapy practice. Advocacy for clientele is central to this improvement, both at individual and structural levels.
Klukken, Angela, Sally Wasmuth, Wasmuth, Sally, Angela Klukken   +3 more
core   +1 more source

Long-term effect of α1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients: an analysis of the AIR database

ERJ Open Research, 2021
Background Patients with ZZ (Glu342Lys) α-1-antitrypsin deficiency (ZZ-AATD) who received augmentation therapy with α-1-antitrypsin (AAT) in randomised controlled trials over 2–3 years failed to show a significant reduction of the annual decline of ...
Iris G.M. Schouten, Marise J. Kasteleyn, Roula Tsonaka, Robert Bals, Alice C. Turner, Ilaria Ferrarotti, Angelo G. Corsico, Beatriz Lara, Marc Miravitlles, Robert A. Stockley, Jan Stolk   +10 more
doaj   +1 more source

zeshankhan/Augmentation: V1.0

, 2023
The augmentation of the images using various types of flips, rotates, crops and ...
Zeshan Khan
core   +1 more source

Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group

International Journal of COPD, 2022
Timm Greulich, 1,* Anna Albert, 1,* Werner Cassel, 2 Tobias Boeselt, 1 Erika Peychev, 1 Andreas Klemmer, 1 Francini Ferrerira, 3 Christian Clarenbach, 4 Maria L Torres-Duran, 5, 6 Alice M Turner, 7 Marc Miravitlles 8 1University Medical Centre Giessen ...
Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, Ferrerira F, Clarenbach C, Torres-Duran ML, Turner AM, Miravitlles M   +10 more
doaj